Wright Medical Group, Inc. to Participate in the 30th Annual J.P. Morgan Healthcare Conference
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, announced today that it will be participating in the 30th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at the Westin St. Francis Hotel in San Francisco, CA. Robert Palmisano, President and Chief Executive Officer, will present at 2:30 p.m. Pacific Time.
A live audio webcast of the conference presentation, along with the accompanying presentation materials, will be available on Wright's corporate website at www.wmt.com/corporate, under the “Investor Info” link. The audio webcast will be archived on this site following the conference. The accompanying presentation materials will be archived under the “Latest Investor Presentation” link.
Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for more than 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Company's website at www.wmt.com.
The conference call and webcast may contain “forward-looking statements” as defined under U.S. federal securities laws. These statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. Forward-looking statements are subject to a number of risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements. Such risks and uncertainties include the impact of Wright's settlement of the federal investigation into Wright's consulting arrangements with orthopaedic surgeons relating to its hip and knee products in the United States, including Wright's compliance with a Deferred Prosecution Agreement through September 2012 and a Corporate Integrity Agreement through September 2015, and those risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2010, under the heading, “Risk Factors” and in Item 1A of Part II of our 10-Qs filed during 2011), including demand for and market acceptance of our new and existing products; future actions of governmental authorities and other third parties; tax measures; business development and growth opportunities; product quality or patient safety issues; products liability claims; enforcement of our intellectual property rights; the geographic and product mix impact on our sales; retention of sales representatives and independent distributors; inventory reductions or fluctuations in buying patterns by wholesalers or distributors; ability to realize the anticipated benefits of restructuring initiatives; and impact of the commercial and credit environment on us and our customers and suppliers. Readers should not place undue reliance on forward-looking statements.
Wright Medical Group, Inc.
Julie D. Tracy, 901-290-5817
Sr. Vice President, Chief Communications Officer